Skip to main content

Find Clinical Trials

Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

NCT03645031

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +13 more
Locations: UF Clinical Research Center Gainesville, Florida, United States

University of Florida Gainesville, Florida, United States

View Trial Details

Completed

A Relational Research Recruitment and Engagement Intervention for Cognitive Aging Research

NCT05444244

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +19 more
Locations: University of Wisconsin-Madison Madison, Wisconsin, United States

View Trial Details

Completed

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

NCT05136885

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Healey Center for ALS at Mass General Boston, Massachusetts, United States

View Trial Details

Completed

TJ-68 Clinical Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) and Muscle Cramps

NCT04998305

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +15 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

Mayo Clinic Jacksonville, Florida, United States

Columbia University Irving Medical Center New York, United States

View Trial Details

Completed

Safety and Tolerance of RAG-17 in Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation

NCT05903690

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Gene Mutation, +9 more
Locations: Beijing Tiantan Hospital Beijing, China

View Trial Details

Completed

Exploratory Evaluation of [11C]MPC6827

NCT04575727

Conditions: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Brain Diseases, +14 more
Locations: Cuimc / Nyp New York, United States

View Trial Details

Completed

Effects of L-Carnitine in Amyotrophic Lateral Sclerosis Patients With CHCHD10 Mutations

NCT06849115

Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations: Xuanwu Hospital, Capital Medical University Beijing, China

View Trial Details

Completed

Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

NCT03548311

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Nagoya University Hospital Nagoya, Aichi-ken, Japan

Miyoshi Neurological Clinic Miyoshi, Hiroshima, Japan

Sapporo Medical University Hospital Sapporo, Hokkaido, Japan

Kobe Central Munincipal Medical center Kobe, Hyōgo, Japan

View all 16 locations

View Trial Details

Completed

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

NCT06165172

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Spaulding Rehabilitation Hospital Charlestown, Massachusetts, United States

View Trial Details

Completed

Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis

NCT05178810

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: University Hospitals Leuven Leuven, Belgium

CHRU de Lille - Hôpital Roger Salengro Lille, France

CHU de Limoges - Hôpital Dupuytren Limoges, France

Centre Hospitalo-Universitaire La Timone Marseille, France

View all 38 locations

View Trial Details